首页> 外文期刊>Bone marrow transplantation >Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.
【24h】

Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.

机译:输注从用副蛋白独特型免疫的供体获得的淋巴细胞,作为复发性骨髓瘤的治疗方法。

获取原文
获取原文并翻译 | 示例
           

摘要

A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling. After transplantation, the disease relapsed. Melphalan therapy followed by reinfusion of haemopoietic blood stem cells collected from the patient led to the improvement of the clinical status, although mixed chimerism and an elevated serum IgA persisted. Successful donor immunisation against an immunogenic preparation of the recipient monoclonal protein was performed before the infusion of donor T lymphocytes (DLI) into the patient. Ten weeks after the lymphocyte infusions, no monoclonal band was evidenced and donor complete chimerism was detected. The patient did not develop GVHD. Once complete remission was achieved, the idiotype vaccine was administered to the patient. Nineteen months after DLI, the patient remains in remission. Bone Marrow Transplantation (2000).
机译:一名48岁IgA k多发性骨髓瘤患者接受了HLA匹配兄弟姐妹的BMT治疗。移植后,疾病复发。尽管混合嵌合和血清IgA持续存在,但Melphalan治疗后再输注从患者体内收集的造血干细胞可改善临床状况。在将供体T淋巴细胞(DLI)注入患者体内之前,针对受​​体单克隆蛋白的免疫原性制剂成功进行了供体免疫。淋巴细胞输注后十周,未发现单克隆带,并且检测到供体完全嵌合。病人没有发展为GVHD。一旦达到完全缓解,就向患者施用独特型疫苗。 DLI后十九个月,患者仍处于缓解状态。骨髓移植(2000年)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号